{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:17:44Z","timestamp":1789737464826,"version":"4.0.1"},"reference-count":37,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2024,3,1]]},"DOI":"10.3724\/abbs.2024009","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T09:31:30Z","timestamp":1705483890000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["miR-34b-3p-mediated regulation of STC2 and FN1 enhances                     chemosensitivity and inhibits proliferation in cervical cancer"],"prefix":"10.3724","author":[{"given":"Shanshan","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence                         and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68: 394-424.","journal-title":"CA Cancer J Clin"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1002\/cncr.30667","volume":"123","author":"Small Jr W","year":"2017","unstructured":"Small Jr W, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, Jhingran A. Cervical cancer: a global health crisis. Cancer, 2017, 123: 2404-2412.","journal-title":"Cancer"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.6004\/jnccn.2020.0027","volume":"18","author":"Abu-Rustum NR","year":"2020","unstructured":"Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C. NCCN guidelines insights: cervical cancer, version 1.2020. J Natl                             Comprehensive Cancer Network, 2020, 18: 660-666.","journal-title":"J Natl                             Comprehensive Cancer Network"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.phrs.2016.01.001","volume":"106","author":"Amable L","year":"2016","unstructured":"Amable L. Cisplatin resistance and opportunities for precision medicine. Pharmacol Res, 2016, 106: 27-36.","journal-title":"Pharmacol Res"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"Lu TX","year":"2018","unstructured":"Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin                             Immunol, 2018, 141: 1202-1207.","journal-title":"J Allergy Clin                             Immunol"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"Rupaimoole R","year":"2017","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of                         cancer and other diseases. Nat Rev Drug Discov, 2017, 16: 203-222.","journal-title":"Nat Rev Drug Discov"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"Hayes J","year":"2014","unstructured":"Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol                             Med, 2014, 20: 460-469.","journal-title":"Trends Mol                             Med"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fonc.2019.00431","volume":"9","author":"Shiomi E","year":"2019","unstructured":"Shiomi E, Sugai T, Ishida K, Osakabe M, Tsuyukubo T, Kato Y, Takata R. Analysis of expression patterns of microRNAs that are closely                         associated with renal carcinogenesis. Front Oncol, 2019, 9:","journal-title":"Front Oncol"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s12935-021-02239-6","volume":"21","author":"Lv H","year":"2021","unstructured":"Lv H, Jin S, Zou B, Liang Y, Xie J, Wu S. Analyzing the whole-transcriptome profiles of ncRNAs and                         predicting the competing endogenous RNA networks in cervical cancer cell                         lines with cisplatin resistance. Cancer Cell Int, 2021, 21:","journal-title":"Cancer Cell Int"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.drudis.2016.10.014","volume":"22","author":"Ganju A","year":"2017","unstructured":"Ganju A, Khan S, Hafeez BB, Behrman SW, Yallapu MM, Chauhan SC, Jaggi M. miRNA nanotherapeutics for cancer. Drug Discov                             Today, 2017, 22: 424-432.","journal-title":"Drug Discov                             Today"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","volume":"21","author":"Goodall GJ","year":"2021","unstructured":"Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer, 2021, 21: 22-36.","journal-title":"Nat Rev Cancer"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13048-021-00919-5","volume":"14","author":"Wang J","year":"2021","unstructured":"Wang J, Liu L. MiR-149-3p promotes the cisplatin resistance and EMT in ovarian                         cancer through downregulating TIMP2 and CDKN1A. J Ovarian Res, 2021, 14:","journal-title":"J Ovarian Res"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"153405","DOI":"10.1016\/j.prp.2021.153405","volume":"220","author":"Li Y","year":"2021","unstructured":"Li Y, Zhang L, Dong Z, Xu H, Yan L, Wang W, Yang Q. MicroRNA-155-5p promotes tumor progression and contributes to                         paclitaxel resistance via TP53INP1 in human breast cancer. Pathol-Res Pract, 2021, 220:","journal-title":"Pathol-Res Pract"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"113733","DOI":"10.1016\/j.bcp.2019.113733","volume":"171","author":"Lin H","year":"2020","unstructured":"Lin H, Hu B, He X, Mao J, Wang Y, Wang J, Zhang T. Overcoming Taxol-resistance in A549 cells: A comprehensive                         strategy of targeting P-gp transporter, AKT\/ERK pathways, and cytochrome                         P450 enzyme CYP1B1 by 4-hydroxyemodin. Biochem                             Pharmacol, 2020, 171:","journal-title":"Biochem                             Pharmacol"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/10409239509083491","volume":"30","author":"Hayes JD","year":"1995","unstructured":"Hayes JD, Pulford DJ. The glutathione S-Transferase supergene family: regulation of GST                         and the contribution of the lsoenzymes to cancer chemoprotection and drug                         resistance Part I. Crit Rev Biochem                             Mol Biol, 1995, 30: 445-600.","journal-title":"Crit Rev Biochem                             Mol Biol"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1093\/nar\/22.15.3005","volume":"22","author":"Larminat F","year":"1994","unstructured":"Larminat F, Bohr VA. Role of the human ERCC-1 gene in gene-specific repair of                         cisplatin-induced DNA damage. Nucl Acids Res, 1994, 22: 3005-3010.","journal-title":"Nucl Acids Res"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/jhg.2017.27","volume":"62","author":"Mizuno K","year":"2017","unstructured":"Mizuno K, Mataki H, Arai T, Okato A, Kamikawaji K, Kumamoto T, Hiraki T. The microRNA expression signature of small cell lung cancer:                         tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes. J Hum Genet, 2017, 62: 671-678.","journal-title":"J Hum Genet"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"R116","DOI":"10.1186\/bcr3059","volume":"13","author":"Lee YM","year":"2011","unstructured":"Lee YM, Lee JY, Ho CC, Hong QS, Yu SL, Tzeng CR, Yang PC. miRNA-34b as a tumor suppressor in estrogen-dependent growth of                         breast cancer cells. Breast Cancer Res, 2011, 13:","journal-title":"Breast Cancer Res"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.3390\/ijms18122762","volume":"18","author":"Fang L","year":"2017","unstructured":"Fang L, Sun B, Huang L, Yuan H, Zhang S, Chen J, Yu Z. Potent inhibition of miR-34b on migration and invasion in                         metastatic prostate cancer cells by regulating the TGF-\u03b2 pathway. Int J Mol Sci, 2017, 18:","journal-title":"Int J Mol Sci"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.12659\/MSM.913746","volume":"25","author":"Tan Y","year":"2019","unstructured":"Tan Y, Zhang T, Zhou L, Liu S, Liang C. MiR-34b-3p represses the multidrug-chemoresistance of bladder                         cancer cells by regulating the CCND2 and P2RY1 genes. Med Sci Monit, 2019, 25: 1323-1335.","journal-title":"Med Sci Monit"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/ijms20030545","volume":"20","author":"C\u00f3rdova-Rivas S","year":"2019","unstructured":"C\u00f3rdova-Rivas S, Fraire-Soto I, Mercado-Casas Torres A, Serv\u00edn-Gonz\u00e1lez L, Granados-L\u00f3pez A, L\u00f3pez-Hern\u00e1ndez Y, Reyes-Estrada C. 5p and 3p strands of miR-34 family members have differential                         effects in cell proliferation, migration, and invasion in cervical cancer                         cells. Int J Mol Sci, 2019, 20:","journal-title":"Int J Mol Sci"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbrc.2016.05.081","volume":"476","author":"Gao W","year":"2016","unstructured":"Gao W, Liu Y, Qin R, Liu D, Feng Q. Silence of fibronectin 1 increases cisplatin sensitivity of                         non-small cell lung cancer cell line. Biochem Biophys                             Res Commun, 2016, 476: 35-41.","journal-title":"Biochem Biophys                             Res Commun"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/CBM-200594","volume":"31","author":"Zhao Q","year":"2021","unstructured":"Zhao Q, Xie J, Xie J, Zhao R, Song C, Wang H, Rong J. Weighted correlation network analysis identifies FN1, COL1A1 and                         SERPINE1 associated with the progression and prognosis of gastric cancer. Cancer Biomark, 2021, 31: 59-75.","journal-title":"Cancer Biomark"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"610547","DOI":"10.3389\/fonc.2021.610547","volume":"11","author":"Sun W","year":"2021","unstructured":"Sun W, Qin Y, Wang Z, Dong W, He L, Zhang T, Zhang H. The NEAT1_2\/miR-491 axis modulates papillary thyroid cancer                         invasion and metastasis through TGM2\/NF\u03baB\/FN1 signaling. Front Oncol, 2021, 11:","journal-title":"Front Oncol"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"756722","DOI":"10.3389\/fimmu.2021.756722","volume":"12","author":"Yang Q","year":"2021","unstructured":"Yang Q, Zhang H, Wei T, Lin A, Sun Y, Luo P, Zhang J. Single-cell RNA sequencing reveals the heterogeneity of                         tumor-associated macrophage in non-small cell lung cancer and differences                         between sexes. Front Immunol, 2021, 12:","journal-title":"Front Immunol"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1002\/ijc.32854","volume":"146","author":"Yoshihara M","year":"2020","unstructured":"Yoshihara M, Kajiyama H, Yokoi A, Sugiyama M, Koya Y, Yamakita Y, Liu W. Ovarian cancer\u2010associated mesothelial cells induce acquired                         platinum\u2010resistance in peritoneal metastasis via the                         FN1\/Akt signaling pathway. Intl J Cancer, 2020, 146: 2268-2280.","journal-title":"Intl J Cancer"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.4161\/cc.21944","volume":"11","author":"Qie S","year":"2012","unstructured":"Qie S, Liang D, Yin C, Gu W, Meng M, Wang C, Sang N. Glutamine depletion and glucose depletion trigger growth                         inhibition via distinctive gene expression reprogramming. Cell Cycle, 2012, 11: 3679-3690.","journal-title":"Cell Cycle"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1016\/j.yexcr.2010.06.026","volume":"316","author":"Law AYS","year":"2010","unstructured":"Law AYS, Wong CKC. Stanniocalcin-2 promotes epithelial-mesenchymal transition and                         invasiveness in hypoxic human ovarian cancer cells. Exp Cell Res, 2010, 316: 3425-3434.","journal-title":"Exp Cell Res"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.yexcr.2009.09.018","volume":"316","author":"Law AYS","year":"2010","unstructured":"Law AYS, Wong CKC. Stanniocalcin-2 is a HIF-1 target gene that promotes cell                         proliferation in hypoxia. Exp Cell Res, 2010, 316: 466-476.","journal-title":"Exp Cell Res"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.canlet.2016.11.039","volume":"388","author":"Wu F","year":"2017","unstructured":"Wu F, Li TY, Su SC, Yu JS, Zhang HL, Tan GQ, Liu JW. STC2 as a novel mediator for Mus81-dependent proliferation and                         survival in hepatocellular carcinoma. Cancer Lett, 2017, 388: 177-186.","journal-title":"Cancer Lett"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1245\/s10434-010-1271-1","volume":"18","author":"Kita Y","year":"2011","unstructured":"Kita Y, Mimori K, Iwatsuki M, Yokobori T, Ieta K, Tanaka F, Ishii H. STC2: a predictive marker for lymph node metastasis in esophageal                         squamous-cell carcinoma. Ann Surg Oncol, 2011, 18: 261-272.","journal-title":"Ann Surg Oncol"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1756-9966-33-26","volume":"33","author":"Lin S","year":"2014","unstructured":"Lin S, Guo Q, Wen J, Li C, Lin J, Cui X, Sang N. Survival analyses correlate stanniocalcin 2 overexpression to                         poor prognosis of nasopharyngeal carcinomas. J Exp Clin Cancer                             Res, 2014, 33:","journal-title":"J Exp Clin Cancer                             Res"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.msec.2017.08.075","volume":"83","author":"Cheng H","year":"2018","unstructured":"Cheng H, Wu Z, Wu C, Wang X, Liow SS, Li Z, Wu YL. Overcoming STC2 mediated drug resistance through drug and gene                         co-delivery by PHB-PDMAEMA cationic polyester in liver cancer cells. Mater Sci Eng-C, 2018, 83: 210-217.","journal-title":"Mater Sci Eng-C"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/mc.23375","volume":"61","author":"Huang S","year":"2022","unstructured":"Huang S, Huang P, Wu H, Wang S, Liu G. LINC02381 aggravates breast cancer through the miR\u20101271\u20105p\/FN1                         axis to activate PI3K\/AKT pathway. Mol Carcinogenesis, 2022, 61: 346-358.","journal-title":"Mol Carcinogenesis"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.18632\/oncotarget.13355","volume":"8","author":"Yang S","year":"2017","unstructured":"Yang S, Ji Q, Chang B, Wang Y, Zhu Y, Li D, Huang C. STC2 promotes head and neck squamous cell carcinoma metastasis                         through modulating the PI3K\/AKT\/Snail signaling. Oncotarget, 2017, 8: 5976-5991.","journal-title":"Oncotarget"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"739478","DOI":"10.3389\/fphar.2022.739478","volume":"13","author":"Wang X","year":"2022","unstructured":"Wang X, Liu Q, Wu S, Xu N, Li H, Feng A. Identifying the effect of celastrol Against ovarian cancer with                         network pharmacology and in vitro experiments. Front Pharmacol, 2022, 13:","journal-title":"Front Pharmacol"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1139\/cjpp-2015-0530","volume":"94","author":"Yuan Q","year":"2016","unstructured":"Yuan Q, Zhan L, Zhang LL, Wang Q, Liu J, Jiang ZY, Hu XM. Stanniocalcin 2 induces oxaliplatin resistance in colorectal                         cancer cells by upregulating P-glycoprotein. Can J Physiol                             Pharmacol, 2016, 94: 929-935.","journal-title":"Can J Physiol                             Pharmacol"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/9FA4062838E748E1A3A588139032D811","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2024009","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/9FA4062838E748E1A3A588139032D811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T07:09:54Z","timestamp":1710313794000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2024009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":37,"URL":"https:\/\/doi.org\/10.3724\/abbs.2024009","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}